Scheduled maintenance This site will be offline from 13:30 to 15:00 CEST on Monday, 21 October 2024 in order to be moved to a new infrastructure. We apologise for the inconvenience. Please check the Slack channel #dc-system-status for updates. The development team can be contacted at datacentre@scilifelab.se if you have any question.

Klingström J

JSON
CSV
XLSX
TXT
Family name Klingström
Given name Jonas
Initials J
ORCID

ORCID 0000-0001-9076-1441
Affiliations Center för Infectious Medicine Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden.
Department of Microbiology Public Health Agency of Sweden Solna Sweden.

19 publications

PubMed DOI Crossref
Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies
Kammann T, Gorin JB, Parrot T, ..., Strålin K, Sandberg JK
The Journal of Immunology 212 (3) 389-396 [2024-02-01; online 2023-12-20]
Category: Serology Type: Journal article
PubMed DOI Crossref
Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.
Bladh O, Greilert-Norin N, Havervall S, ..., Klingström J, Thålin C
N Engl J Med 389 (17) 1626-1628 [2023-10-26; online 2023-10-27]
Category: Biochemistry Category: Genomics & transcriptomics Category: Health Funder: KAW/SciLifeLab National COVID program Type: Journal article
PubMed DOI Crossref
Comprehensive proteomics and meta-analysis of COVID-19 host response.
Babačić H, Christ W, Araújo JE, ..., Klingström J, Pernemalm M
Nat Commun 14 (1) 5921 [2023-09-22; online 2023-09-22]
Category: Other Category: Proteins Funder: KAW/SciLifeLab National COVID program Funder: VR Type: Journal article
PubMed DOI Crossref
Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19.
Yu M, Charles A, Cagigi A, ..., Loré K, Smed-Sörensen A
Nat Commun 14 (1) 2164 [2023-04-15; online 2023-04-15]
Category: Biochemistry Category: Health Type: Journal article
DOI Crossref
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
Marking U, Havervall S, Norin NG, ..., Klingström J, Thålin C
Nat Commun 14 (1) - [2023-03-22; online 2023-03-22]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Type: Journal article
PubMed DOI Crossref
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.
Havervall S, Marking U, Svensson J, ..., Smed-Sörensen A, Thålin C
N Engl J Med 387 (14) 1333-1336 [2022-10-06; online 2022-09-14]
Category: Biochemistry Category: Health Category: Omicron VoC Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Type: Journal article
PubMed DOI Crossref
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.
Monteil V, Eaton B, Postnikova E, ..., Wirnsberger G, Penninger JM
EMBO Mol Med 14 (8) e15230 [2022-08-08; online 2022-07-04]
Category: Biochemistry Category: Health Type: Journal article
PubMed DOI Crossref
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.
Marking U, Havervall S, Greilert-Norin N, ..., Åberg M, Thålin C
Vaccines 10 (3) 359 [2022-02-24; online 2022-02-24]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.
Kaku CI, Champney ER, Normark J, ..., Forsell MNE, Walker LM
Science - (-) eabn2688 [2022-02-10; online 2022-02-10]
Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab National COVID program Type: Journal article
PubMed DOI Crossref
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Havervall S, Jernbom Falk A, Klingström J, ..., Nilsson P, Thålin C
PLoS One 17 (1) e0262169 [2022-01-12; online 2022-01-12]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
DOI Crossref
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
Havervall S, Marking U, Greilert‐Norin N, ..., Åberg M, Thålin C
Clin Transl Immunol 11 (4) - [2022-01-00; online 2022-04-18]
Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S, Ng H, Jernbom Falk A, ..., Hober S, Thålin C
J Intern Med 291 (1) 72-80 [2022-01-00; online 2021-09-27]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Research Area: Viral sequence evolution
PubMed DOI Crossref
High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.
Lourda M, Dzidic M, Hertwig L, ..., Chambers BJ, Karolinska KI/K COVID-19 Study Group
Proc Natl Acad Sci U S A 118 (40) - [2021-10-05; online 2021-09-23]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Type: Journal article
PubMed DOI Crossref
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
Normark J, Vikström L, Gwon YD, ..., Ahlm C, Forsell M
N Engl J Med 385 (11) 1049-1051 [2021-09-09; online 2021-09-09]
Category: Biochemistry Category: Drug Discovery Category: Vaccines Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Vaccine Type: Journal article
PubMed DOI Crossref
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
Havervall S, Marking U, Greilert-Norin N, ..., Åberg M, Thålin C
EBioMedicine 70 (-) 103523 [2021-08-00; online 2021-08-12]
Category: Drug Discovery Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.
Hober S, Hellström C, Olofsson J, ..., Hedhammar M, Nilsson P
Clin Transl Immunol 10 (7) e1312 [2021-07-19; online 2021-07-19]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.
Sandberg JT, Varnaitė R, Christ W, ..., Gredmark-Russ S, Karolinska COVID‐19 Study Group
Clin Transl Immunol 10 (7) e1306 [2021-07-05; online 2021-07-05]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Varnaitė R, García M, Glans H, ..., Klingström J, Gredmark-Russ S
J Immunol 205 (9) 2437-2446 [2020-11-01; online 2020-09-02]
Category: Biochemistry Category: Health Category: Proteins Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
Natural killer cell immunotypes related to COVID-19 disease severity.
Maucourant C, Filipovic I, Ponzetta A, ..., Björkström NK, Karolinska COVID-19 Study Group
Sci Immunol 5 (50) - [2020-08-21; online 2020-08-23]
Category: Biochemistry Category: Genomics & transcriptomics Category: Health Category: Imaging Category: Other Category: Proteins Funder: KAW/SciLifeLab National COVID program Funder: VR Funder: VR: Special COVID-19 funding Research Area: Data-driven research – models and AI Research Area: Diagnostics for virus Research Area: Host cell systems biology and targets Type: Journal article
SciLifeLab Data Centre
Publications 9.5.1-pretest